ICOPE could constitute the reference model of care for healthy aging. More specifically, our hypothesis is that the intervention implemented in ICOPE may directly or indirectly prevent immuno-senescence, the loss of mobility and the cognitive decline. In future Geroscience clinical trials, ICOPE-Intense could become a benchmark to reduce the rate of aging with a strong non-pharmacological intervention and state a reference intervention to compare with new gerotherapeutic drugs.
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Estimation of the effect size of the intervention on the cognitive function
Timeframe: 60 days
Estimation of the effect size of the intervention on the muscle function
Timeframe: 60 days
Estimation of the effect size of the intervention on the immune function
Timeframe: 60 days